Xenon Pharmaceuticals Inc.'s XEN1101 shows promise in epilepsy with strong phase 2b results and solid financials. Click here ...

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares lost ground Friday, as the neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing ...

Food - Microbial contamination - E. Coli - other pathogenic DistributionOntario Online link SOURCE Canadian Food Inspection Agency (CFIA) ...

Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meetingLong-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in focal onset ...

Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine ...

Mike Patterson, Curium's North American Chief Executive Officer said: "Customers are looking to simplify their business. Our ...

Austrian guide Lukas Furtenbach will lead a one-week trip to the top of Everest and back this year. Prior to the ascent, he ...

The Onyango and Tarus company has listed a Ksh55,000 Nissan Pulsar among 39 vehicles that are up for auction. In a notice on ...

StockNews.com upgraded shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. Several other analysts also recently ...

Noting that these thrusters use Xenon as the propellant, the ISRO said the Specific Impulse of the Electric Propulsion System, which is a major performance indicator of a space propulsion system, is ...

ISRO has successfully completed a 1,000-hour life test for its 300mN Stationary Plasma Thruster, designed for the Electric ...